Not Signed In -
Valdecoxib |
Bextra |
Valdecoxib 4-(5-methyl-3-phenyl-4-isoxazolyl)-benzenesulfonamide CAS number 181695-72-7 ATC code M01AH03 Chemical formula C16H14N2O3S Molecular weight 314.364 Bioavailability 83% Metabolism 10% Elimination half-life 8-11 hours Excretion 90% Pregnancy category In late pregnancy, valdecoxib should be avoided because it may cause premature closure of the ductus arteriosus. Legal status Recalled in US, EU, Canada & parts of Asia Routes of administration 10mg Oral ...
Wikipedia - [full article]
Valdecoxib Clinical Trials
- Perioperative Inflammation and Cyclooxygenase 2 (COX-2)
ClinicalTrials.gov Identifier: NCT00122096 - Active, not recruiting
Neurosurgery; Pain
- Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After ERCP
ClinicalTrials.gov Identifier: NCT00419549 - Recruiting
ERCP; Pancreatitis
- Valdecoxib in Treating Chronic Pain in Cancer Patients
ClinicalTrials.gov Identifier: NCT00021996 - Completed
Pain; unspecified adult solid tumor, protocol specific
- Genetic Basis For Variation In NSAID Analgesia In A Clinical Model Of Acute Pain
ClinicalTrials.gov Identifier: NCT00115752 - Completed
- Effect of Valdecoxib Pretreatment on Pain and Secondary Hyperalgesia in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00260325 - Completed
Pain; Hyperalgesia
email this page
print this page
bookmark this page
feedback on this page
